Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India’.
The above information is a part of company’s filings submitted to BSE.